Morning Movers 12/05: (SFSF) (ATHX) (AFFY) (TLEO) Higher; (GLUU) (VISN) Lower
Tweet
Share
E-mail
Get Alerts SFSF Hot Sheet
Join SI Premium – FREE
SuccessFactors, Inc. (NYSE: SFSF) 51.4% HIGHER; SAP AG (NYSE: SAP) announced an agreement Saturday afternoon to acquire SuccessFactors for $40.00/per share in cash, representing an enterprise value of approximately $3.4 billion.
Athersys (Nasdaq: ATHX) 37.4% HIGHER; breaking through the $2 level for the first time since early September this morning. About an hour and a half into the trading session, the stock has already traded more than 3 times its normal full-day volume.
Affymax (Nasdaq: AFFY) 19.4% HIGHER; share are rallying in pre-market trade Monday morning following news out of the FDA the company's anemia drug peginesatide works as well as Amgen's (Nasdaq: AMGN) epogen, aranesp. The FDA note comes ahead of a December 7th advisory panel review of the product
Taleo (Nasdaq: TLEO) 19.1% HIGHER; likely trading higher amid the deal for SuccessFactors. The stock was upgraded at BMO early this morning.
Frontline (NYSE: FRO) 15.1% HIGHER; stock bouncing nicely today as Oslo-based First Securities issued a note earlier suggesting traders may have closed short bets on the stock. Shares plunged from almost $6 to below $3 in November following Q3 results and news the company will not pay a quarterly dividend.
Zalicus Inc. (Nasdaq: ZLCS) 14.5% HIGHER; has initiated a Phase 1 clinical trial evaluating the pharmacokinetics and safety of a new formulation of Z160 (formerly NMED-160), a novel oral N-type calcium channel blocker. Z160 has been reformulated with multiple state-of-the-art delivery techniques to address previous solubility and bioavailability issues.
Kenexa (Nasdaq: KNXA) 14.1% HIGHER; likely seeing upside amid the deal for SuccessFactors.
Saba Software (Nasdaq: SABA) 13.5% HIGHER; see Kenexa.
Gannett (NYSE: GCI) 12.5% HIGHER; Lazard upgraded the stock from Neutral to Buy earlier, citing increased potential for a dividend raise.
Alexza Pharma (Nasdaq: ALXA) 11.8% HIGHER; holding over $1 and seems like its bouncing off the 200-day SMA.
Tenet Healthcare (NYSE: THC) 11.6% HIGHER; in a research note this morning, Goldman Sachs said a decline in hospital stocks last week was an overreaction.
Glu Mobile (Nasdaq: GLUU) 9.7% LOWER; traders are taking profits this morning following a 30 percent increase starting on Wednesday of last week.
VisionChina (Nasdaq: VISN) 9.7% LOWER; after breaking out (up 27 percent) on what seemed to be technicals on Friday, traders are taking profits this morning.
Athersys (Nasdaq: ATHX) 37.4% HIGHER; breaking through the $2 level for the first time since early September this morning. About an hour and a half into the trading session, the stock has already traded more than 3 times its normal full-day volume.
Affymax (Nasdaq: AFFY) 19.4% HIGHER; share are rallying in pre-market trade Monday morning following news out of the FDA the company's anemia drug peginesatide works as well as Amgen's (Nasdaq: AMGN) epogen, aranesp. The FDA note comes ahead of a December 7th advisory panel review of the product
Taleo (Nasdaq: TLEO) 19.1% HIGHER; likely trading higher amid the deal for SuccessFactors. The stock was upgraded at BMO early this morning.
Frontline (NYSE: FRO) 15.1% HIGHER; stock bouncing nicely today as Oslo-based First Securities issued a note earlier suggesting traders may have closed short bets on the stock. Shares plunged from almost $6 to below $3 in November following Q3 results and news the company will not pay a quarterly dividend.
Zalicus Inc. (Nasdaq: ZLCS) 14.5% HIGHER; has initiated a Phase 1 clinical trial evaluating the pharmacokinetics and safety of a new formulation of Z160 (formerly NMED-160), a novel oral N-type calcium channel blocker. Z160 has been reformulated with multiple state-of-the-art delivery techniques to address previous solubility and bioavailability issues.
Kenexa (Nasdaq: KNXA) 14.1% HIGHER; likely seeing upside amid the deal for SuccessFactors.
Saba Software (Nasdaq: SABA) 13.5% HIGHER; see Kenexa.
Gannett (NYSE: GCI) 12.5% HIGHER; Lazard upgraded the stock from Neutral to Buy earlier, citing increased potential for a dividend raise.
Alexza Pharma (Nasdaq: ALXA) 11.8% HIGHER; holding over $1 and seems like its bouncing off the 200-day SMA.
Tenet Healthcare (NYSE: THC) 11.6% HIGHER; in a research note this morning, Goldman Sachs said a decline in hospital stocks last week was an overreaction.
Glu Mobile (Nasdaq: GLUU) 9.7% LOWER; traders are taking profits this morning following a 30 percent increase starting on Wednesday of last week.
VisionChina (Nasdaq: VISN) 9.7% LOWER; after breaking out (up 27 percent) on what seemed to be technicals on Friday, traders are taking profits this morning.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- Truist Financial Corp. (TFC) Declares $0.52 Quarterly Dividend; 5.3% Yield
- Cadre Holdings (CDRE) Declares $0.0875 Quarterly Dividend; 1% Yield
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Lazard, Dividend, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
